trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['bcsm']
important questions to the future: will her2 test necessary for using t-dxd? will we perform her2, trop2 and her3 testing at baseline to choose the adcs in the metastatic setting? #adc #tdxd #saci #dato #patri #bcsm #asco22 #asco2022
Medical Oncologist and scholar at Hospital Sírio-Libanês #brasilia. #Breastcancer  #Immunotherapy #clinicalresearch. Tweets are my own not medical advice.